Product
High Dose Recombinant Herpes Zoster Vaccine
Aliases
High Dose Recombinant Herpes Zoster Vaccine (CHO cells)
2 clinical trials
2 indications
Indication
Herpes ZosterIndication
Vaccine-Preventable DiseasesClinical trial
A Phase I, Single Center, Randomized, Blinded, Controlled Clinical Trial to Evaluate the Safety, Tolerability and Preliminary Immunogenicity of Recombinant Herpes Zoster Vaccine (CHO Cells) in Healthy Subjects Aged 18 Years and AboveStatus: Active (not recruiting), Estimated PCD: 2024-12-30
Clinical trial
A Randomized, Double-blind, Placebo-controlled Phase I Clinical Study to Evaluate Safety and Tolerability of a Recombinant Herpes Zoster Vaccine (LZ901) in Subjects Aged 50 to 70 Years InclusiveStatus: Recruiting, Estimated PCD: 2024-02-01